This article provides an overview of recent news in the AI space, including the acquisition of two Canadian AI drug-discovery companies by Recursion, Bessemer…
Browsing: Recursion
Recursion, a leading clinical stage TechBio company, has signed agreements to acquire two companies in the AI-enabled drug discovery space: Cyclica and Valence. The…
Recursion, a leading clinical stage TechBio company, has announced the acquisition of two companies in the AI-enabled drug discovery space: Cyclica and Valence. The…